稳健医疗ESG治理深化 绿色创新与责任担当共筑“百年稳健”

Core Viewpoint - The company has announced a comprehensive upgrade of its ESG (Environmental, Social, and Governance) strategy, aiming to integrate sustainability into its operations and create a positive cycle between value creation and social responsibility [2][11]. Group 1: ESG Strategy Overview - The company’s vision is to "care for health, cherish life, and protect the environment," structured around five pillars: "Guarding the Earth," "Product Leadership," "Employee Growth," "Community Promotion," and "Steady Governance" [2]. - The "Guarding the Earth" pillar focuses on climate change and carbon target management, promoting green manufacturing and circular economy exploration [2]. - "Product Leadership" emphasizes sustainable and high-quality products as core competitiveness, accelerating the application of green packaging and eco-friendly materials through innovation [2]. - The "Employee Growth" pillar highlights a people-oriented approach, enhancing human capital development and promoting diversity and employee welfare [2]. - "Community Promotion" prioritizes social value, expanding public welfare practices to improve medical accessibility [2]. - "Steady Governance" aims to strengthen business ethics, compliance management, and information security through a robust governance framework [2]. Group 2: Governance and Compliance - The company has optimized its governance structure, ensuring effective collaboration among the shareholders' meeting, board of directors, supervisory board, and management [3]. - The board consists of seven members, including three independent directors and three female directors, reflecting a commitment to gender balance and professional diversity [3]. - The company has established a pre-communication mechanism for major decisions, ensuring scientific and transparent decision-making [3]. - In 2024, the company will hold a board and supervisory board re-election, incorporating a free speech session for outgoing and incoming members to maintain governance culture [3]. Group 3: Investor Relations and Financial Performance - The company maintains a multi-dimensional communication mechanism with over 1,200 institutional investors, significantly exceeding industry peers in research coverage [4]. - In 2024, the company plans to implement a mid-term dividend for the first time, with an annual dividend rate reaching 54% [4]. - Cumulatively, dividends and share buybacks since listing have accounted for 100.3% of the net funds raised [5]. Group 4: Green Innovation and Sustainability - The company has integrated carbon strategies into its planning, aiming for peak carbon emissions and carbon neutrality [6]. - It has received national recognition for its green factory initiatives and has developed systematic plans for water resource management and waste management [6]. - The company emphasizes innovation in sustainable materials, launching new products that address consumer health and environmental concerns [7]. Group 5: Social Responsibility and Community Engagement - The company prioritizes social value over corporate value, actively engaging in community support and disaster response [9]. - It has initiated programs to support women's health and education, collaborating with organizations to provide health packages to underprivileged girls [10]. - The company promotes responsible supply chain management, ensuring environmental and social impact assessments for suppliers [11]. Group 6: Future Outlook - The company aims to embed ESG principles into its development DNA, positioning itself as a benchmark for ESG practices in the healthcare and consumer goods sectors [11]. - With ongoing international expansion and a commitment to green strategies, the company is expected to contribute significantly to the sustainable development of the global health industry [11].